Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2007 1
2008 3
2009 4
2010 1
2011 1
2013 2
2014 4
2015 2
2016 2
2017 2
2019 7
2020 7
2021 7
2022 6
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Unilateral Multifocal Inner Ear and Internal Auditory Canal or Cerebellopontine Angle Cochleovestibular Schwannomas-Genetic Analysis and Management by Surgical Resection and Cochlear Implantation.
Plontke SK, Hoffmann K, Caye-Thomasen P, Baasanjav S, Kösling S, Leisz S, Liebau A, Mawrin C, Rahne T, Scheffler J, Strauss C, Siebolts U. Plontke SK, et al. Among authors: siebolts u. Otol Neurotol. 2024 Mar 4. doi: 10.1097/MAO.0000000000004163. Online ahead of print. Otol Neurotol. 2024. PMID: 38437842
Clinicopathologic and molecular characteristics of small-scale ROS1-mutant non-small cell lung cancer (NSCLC) patients.
Glaser M, Rasokat A, Prang D, Nogova L, Wömpner C, Schmitz J, Bitter E, Terjung I, Eisert A, Fischer R, John F, von Levetzow C, Michels S, Riedel R, Ruge L, Scharpenseel H, Siebolts U, Merkelbach-Bruse S, Buettner R, Brägelmann J, Wolf J, Scheffler M. Glaser M, et al. Among authors: siebolts u. Lung Cancer. 2023 Oct;184:107344. doi: 10.1016/j.lungcan.2023.107344. Epub 2023 Aug 12. Lung Cancer. 2023. PMID: 37579577 Free article.
[ROS1: rearrangements and analytics].
Siebolts U, Merkelbach-Bruse S. Siebolts U, et al. Pathologie (Heidelb). 2023 Feb;44(1):50-52. doi: 10.1007/s00292-022-01162-5. Epub 2022 Nov 15. Pathologie (Heidelb). 2023. PMID: 36378287 German. No abstract available.
Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors-A Retrospective Multi-Center Registry Analysis.
Koehler VF, Adam P, Fuss CT, Jiang L, Berg E, Frank-Raue K, Raue F, Hoster E, Knösel T, Schildhaus HU, Negele T, Siebolts U, Lorenz K, Allelein S, Schott M, Spitzweg C, Kroiss M; German Study Group for Rare Malignant Tumors of the Thyroid and Parathyroid Glands. Koehler VF, et al. Among authors: siebolts u. Cancers (Basel). 2022 Jul 13;14(14):3405. doi: 10.3390/cancers14143405. Cancers (Basel). 2022. PMID: 35884466 Free PMC article.
New Safety Aspects in Corneal Donation-Studies on SARS-CoV-2-Positive Corneal Donors.
Wille D, Heinzelmann J, Kehlen A, Lütgehetmann M, Nörz DS, Siebolts U, Mueller A, Karrasch M, Hofmann N, Viestenz A, Börgel M, Kuhn F, Viestenz A. Wille D, et al. Among authors: siebolts u. J Clin Med. 2022 Jun 9;11(12):3312. doi: 10.3390/jcm11123312. J Clin Med. 2022. PMID: 35743381 Free PMC article.
52 results